Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intrexon Corp (NYSE:XON)

35.97
Delayed Data
As of Feb 05
 +1.01 / +2.89%
Today’s Change
18.52
Today|||52-Week Range
69.45
+19.30%
Year-to-Date

Today’s Trading

Previous close34.96
Today’s open34.75
Day’s range33.17 - 36.83
Volume2,972,373
Average volume (3 months)2,285,928
Market cap$4.2B
Dividend yield--
Data as of 4:02pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)+40.71%
Earnings growth (this year)+20.89%
Earnings growth (next 5 years)-78.25%
Revenue growth (last year)+202.74%
P/E ratioNM
Price/Sales37.96
Price/Book9.40

Competitors

 Today’s
change
Today’s
% change
CTLTCatalent Inc-0.52-2.34%
JUNOJuno Therapeutics In...+0.77+3.00%
KITEKite Pharma Inc-5.72-12.12%
OPHTOphthotech Corp-2.86-5.32%
Data as of 4:01pm ET, 02/05/2016

Financials

Next reporting dateFebruary 29, 2016
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$71.9M
Annual profit (last year)-$81.8M
Net profit margin-113.75%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Randal J. Kirk
Chief Operating Officer
Krish S. Krishnan
Corporate headquarters
Germantown, Maryland

Forecasts

Partner Offers